Skip to main content
Arjan Diepstra
dr.

As a hematopathologist, I work on diagnostics of all types of hematological malignancies using a comprehensive panel of different techniques. Moreover, my main research interest involves Hodgkin lymphoma, with a strong focus on interactions between tumor cells and the microenvironment. In addition, I also have a long standing interest in genetic susceptibility. My areas of expertise are: immunology, tumor cell biology, genetic association studies and molecular diagnostics in pathology. I actively participate in international (EORTC) and national (HOVON) clinical trials.

Membership PhD-committee Kushi Kushekhar

Human leukocyte antigen and classical Hodgkin lymphoma. Genetic predisposition and susceptibility mechanisms

Period 1-Apr-2010 → 26-Jan-2015
Examinee Kushi Kushekhar
Examination held at University of Groningen
Degree of Recognition Local
Membership PhD-committee X. Huang

Classical Hodgkin lymphoma in Chinese and Dutch populations

Period 9-Sept-2008 → 20-Jun-2011
Examinee Xin Huang
Examination held at University of Groningen
Degree of Recognition Local
The interplay between CD T cells and tumor cells in Hodgkin lymphoma.

Johanna Veldman, December 8th 2021, Rijks Universiteit Groningen, promotores Dr. A. Diepstra and Prof. J.H.M. van den Berg, copromotor Dr. A. Visser. The interplay between CD T cells and tumor cells in Hodgkin lymphoma. [100th thesis evaluation]

Period 8-Dec-2021
Examinee Hanna Veldman
Examination held at University of Groningen
Degree of Recognition Local
Member PhD-committee Peijia Jiang

Human leukocyte antigen-related susceptibility mechanisms in Hodgkin lymphoma. [evaluation committeere only]

Period 1-Oct-2016 → 12-Dec-2021
Examinee Peijia Jiang
Examination held at University of Groningen
Degree of Recognition Local
Interlymph annual meeting

Talk: ERAP1 and ERAP2 susceptibility mechanisms in Hodgkin lymphoma

Period 27-Jun-2018
Event title Interlymph annual meeting
Event type Conference
Location Chicago, United StatesShow on map
Degree of Recognition International